Sarepta Therapeutics (SRPT) volatility at five-week lows as shares rally into FDA decision on eteplirsen

August 24, 2016 12:16 PM EDT

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

Sarepta Therapeutics (NASDAQ: SRPT) August weekly call option implied volatility is at 191, September weekly is at 178, September is at 189, October is at 196, November is at 176; compared to its 52-week range of 67 to 399 into FDA decision regarding eteplirsen.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Options, Trader Talk

Related Entities

Options

Add Your Comment